2',3',5'-tri-O-acetyluridine,
PN 401,
PN-401,
PN401,
RG-2133,
RG2133,
triacetyluridine,
uridine triacetate,
Xuriden,
Uridine triacetate,
4105-38-8,
2',3',5'-Tri-O-acetyluridine,
Triacetyluridine,
Tri-O-acetyluridine,
Vistonuridine,
Uridine 2',3',5'-triacetate,
Xuriden,
PN401,
UNII-2WP61F175M,
(2R,3R,4R,5R)-2-(ACETOXYMETHYL)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)TETRAHYDROFURAN-3,4-DIYL DIACETATE,
Uridine, 2',3',5'-triacetate,
PN 401,
RG 2133,
2WP61F175M,
MFCD00023795,
2 ,3 ,5 -Triacetyluridine,
Vistogard,
triacetyl uridine,
Uridine triacetate [USAN:INN],
AK-73070,
EINECS 223-881-5,
Xuriden (TN),
PubChem14176,
AC1L2FGB,
KSC495Q6D,
MLS006009982,
SCHEMBL871011,
URI007,
CHEMBL2107381,
Uridine triacetate (USAN/INN),
CHEBI:90914,
CTK3J5861,
AUFUWRKPQLGTGF-FMKGYKFTSA-N,
ZINC3843198,
AN-158,
ANW-29551,
AKOS015964563,
API0001026,
DB09144,
SB18970,
SMR004701034,
AX8007900,
2',3',5'-Tri-O-acetyluridine, >=98%,
FT-0081134,
D09985,
105T388,
J-700012,
[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl acetate,
[(2R,3R,4R,5R)-3,4-diacetoxy-5-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-2-yl]methyl acetate,
2',3',5'-Triacetyluridine,
D0OL7F,
C15H18N2O9,
CID20058,
NSC79269,
C15-H18-N2-O9,
2',3',5'-Tri-O-acetyluridine, 98% - 1G 1g,
N/A,